PRF Technologies Reports Expanded Preclinical Results for PRF-110 in Head-to-Head Comparison with Approved Benchmark
Go back to PRF Technologies Reports Expanded Preclinical Results for PRF-110 in Head-to-Head Comparison with Approved Benchmark| (NASDAQ: PRFX) | Delayed: 1.15 -0.05 (4.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.20 | 52 Week High | $ | |||
| Open | $1.20 | 52 Week Low | $ | |||
| Day High | $1.20 | P/E | N/A | |||
| Day Low | $1.13 | EPS | $ | |||
| Volume | 85,380 | |||||

